| GC17161-5mg |
|
289726-02-9 |
Methylpiperidino pyrazole
|
0 |
C29H31N3O3 |
|
|
|
| GC17160-50mg |
|
52806-53-8 |
|
0 |
C11H11F3N2O4 |
|
|
|
| GC17160-25mg |
|
52806-53-8 |
|
0 |
C11H11F3N2O4 |
|
|
|
| GC17160-10mg |
|
52806-53-8 |
|
0 |
C11H11F3N2O4 |
|
|
|
| GC17160-5mg |
|
52806-53-8 |
|
0 |
C11H11F3N2O4 |
|
|
|
| GC17159-10mM (in 1mL DMSO) |
|
256383-45-6 |
4-(n-nonyl) Benzeneboronic Acid
|
0 |
C15H25BO2 |
|
|
|
| GC17159-1g |
|
256383-45-6 |
4-(n-nonyl) Benzeneboronic Acid
|
0 |
C15H25BO2 |
|
|
|
| GC17159-500mg |
|
256383-45-6 |
4-(n-nonyl) Benzeneboronic Acid
|
0 |
C15H25BO2 |
|
|
|
| GC17158-1g |
|
1042224-63-4 |
|
0 |
C17H19N5 |
|
|
|
| GC17158-500mg |
|
1042224-63-4 |
|
0 |
C17H19N5 |
|
|
|
| GC17158-50mg |
|
1042224-63-4 |
|
0 |
C17H19N5 |
|
|
|
| GC17158-10mg |
|
1042224-63-4 |
|
0 |
C17H19N5 |
|
|
|
| GC17158-5mg |
|
1042224-63-4 |
|
0 |
C17H19N5 |
|
|
|
| GC17157-1g |
|
153504-70-2 |
Cevimeline hydrochloride hemihydrate
|
0 |
C10H20ClNO2S |
|
|
|
| GC17157-50mg |
|
153504-70-2 |
Cevimeline hydrochloride hemihydrate
|
0 |
C10H20ClNO2S |
|
|
|
| GC17157-25mg |
|
153504-70-2 |
Cevimeline hydrochloride hemihydrate
|
0 |
C10H20ClNO2S |
|
|
|
| GC17157-10mg |
|
153504-70-2 |
Cevimeline hydrochloride hemihydrate
|
0 |
C10H20ClNO2S |
|
|
|
| GC17156-1mg |
|
108437-88-3 |
|
0 |
C75H114N22O18 |
|
|
|
| GC17155-50mg |
|
207403-36-9 |
|
0 |
C23H36N2O.HCl |
|
|
|
| GC17155-10mg |
|
207403-36-9 |
|
0 |
C23H36N2O.HCl |
|
|
|
